Gossypol (AT-101) and Temozolomide With or Without Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme

NCT00390403 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

50

Enrollment

OTHER

Sponsor class

Conditions

Brain and Central Nervous System Tumors

Interventions

DRUG: R-(-)-gossypol acetic acid
DRUG: temozolomide
GENETIC: gene expression analysis
GENETIC: mutation analysis
GENETIC: protein expression analysis
OTHER: laboratory biomarker analysis
OTHER: pharmacological study
PROCEDURE: adjuvant therapy
RADIATION: radiation therapy

Sponsor

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Collaborators

[object Object]